User profiles for Ming Shi

Ming Shi

Cancer Center, Sun Yat-sen University
Verified email at sysu.edu.cn
Cited by 5000

Single-cell landscape of immunological responses in patients with COVID-19

…, RN Xu, XP Dai, L Shi, L Huang, TJ Jiang, M Shi… - Nature …, 2020 - nature.com
In coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, the relationship between disease severity and the host …

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

…, M Gou, W Huang, Y Wang, C Fan, Z Tian, M Shi… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory disease
called coronavirus disease 2019 (COVID-19), the spread of which has led to a pandemic. …

PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients

F Shi, M Shi, Z Zeng, RZ Qi, ZW Liu… - … journal of cancer, 2011 - Wiley Online Library
… Feng Shi and Ming Shi contributed equally to this study. … Feng Shi and Ming Shi
contributed equally to this study. … Feng Shi and Ming Shi contributed equally to this study. …

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

J Fu, D Xu, Z Liu, M Shi, P Zhao, B Fu, Z Zhang, H Yang… - Gastroenterology, 2007 - Elsevier
BACKGROUND & AIMS: Recent studies have suggested that CD4 + CD25 + regulatory T
cells (Treg) are increased and linked to compromised immune responses in patients with …

2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China

…, L Liu, W Bu, H Cheng, S Zhang, L Yang, M Shi… - MedRxiv, 2020 - medrxiv.org
The outbreak of COVID-19 originated in Wuhan has become a global epidemic of contagious
diseases, which poses a serious threat to human life and health, especially for those with …

[PDF][PDF] Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis

…, S Zhang, B Li, TJ Jiang, R Wang, Z Wang, M Shi… - Cell metabolism, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented threat to
global public health. Herein, we utilized a combination of targeted and untargeted tandem …

Immunological and inflammatory profiles in mild and severe cases of COVID-19

…, TJ Jiang, WG Li, DW Zhang, P Zhao, M Shi… - Nature …, 2020 - nature.com
COVID-19 is associated with 5.1% mortality. Although the virological, epidemiological, clinical,
and management outcome features of COVID-19 patients have been defined rapidly, the …

Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

…, C Zhou, Z Zou, JM Zhao, B Zhang, M Shi… - The Journal of …, 2006 - journals.aai.org
CD4+ CD25+ regulatory T cells (Treg) have been shown to maintain immune tolerance
against self and foreign Ags, but their role in persistent viral infection has not been well-defined. …

Energy frameworks: insights into interaction anisotropy and the mechanical properties of molecular crystals

MJ Turner, SP Thomas, MW Shi, D Jayatilaka… - Chemical …, 2015 - pubs.rsc.org
We present an approach to understanding crystal packing via ‘energy frameworks’, that
combines efficient calculation of accurate intermolecular interaction energies with a novel …

[PDF][PDF] Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B

…, F Lin, ZS Zou, RN Xu, L Jin, JL Fu, F Shi, M Shi… - …, 2010 - Wiley Online Library
Interleukin‐17 (IL‐17)‐producing CD4 + T cells (Th17)‐mediated immune response has been
demonstrated to play a critical role in inflammation‐associated disease; however, its role …